- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04004156
Safety Study for An Artificial Disc Replacement to Treat Chronic Low Back Pain
July 13, 2021 updated by: Spinal Stabilization Technologies
Safety Study for An Artificial Disc Replacement "PerQdisc Nucleus Replacement Device" NUCLEUS 181
This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device (NRD).
The NRD is used for surgical replacement of a single nucleus pulposus between spinal lumbar discs L1-S1 using an anterior or lateral transpsoas approach.
Currently the surgical gold standard involves spinal fusion of the affected vertebral bodies, reducing range of motion and increasing stress on other vertebral bodies.
The goal of nucleus replacement is to reduce chronic low back pain by maintaining disc height while preserving range of motion.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient is skeletally mature and between 22 and 60 years of age.
- Patient has degenerative disc disease (DDD) at a single level between L1 and S1 as confirmed by:History and clinical findings suggestive of symptomatic DDD, Darkened disc on MRI in T2 weighted images, and decreased disc height (decreased greater than 2 mm compared to adjacent cranial or caudal disc height) with minimum disc height of 6 mm.
- Patient has pre-operative back pain VAS score of greater than or equal to 4 (0-10 scale).
- Patient has pre-operative Oswestry Low Back Disability score of greater than or equal to 40 (0-100 scale).
- Patient has received conservative (non-surgical) treatment for back pain for a minimum of 6 months.
- Patient has signed the approved Informed Consent Form.
Exclusion Criteria:
- Patient has had prior lumbar spine surgery.
- Patient has motion of less than 3 degrees on pre-operative lateral flexion/extension radiographs.
- Patient has ankylosing spondylitis or other spondyloarthropathy.
- Patient has isthmic spondylolisthesis or degenerative spondylolisthesis greater than 2 mm.
- Patient has congenital stenosis or epidural lipomatosis.
- Patient has significant facet disease.
- Patient has any known active malignancy.
- Patient has previously undergone immunosuppressive therapy.
- Patient has active local or system infection.
- Patient has been diagnosed with hepatitis, rheumatoid arthritis, lupus erythematosus, or other autoimmune disease, including AIDS, ARC and HIV
- Patient has diabetes mellitus (Type 1 or 2), requiring daily insulin management.
- Patient has osteopenia of the spine (T-score less than 1.0). All females 45 years of age or older and all males 50 or older should have a DEXA scan to confirm this exclusion.
- Patient has morbid obesity defined as body mass index (BMI) more than 40 or a weight of more than 45 kg (100 lbs) over ideal body weight.
- Patient is pregnant or plans to become pregnant during the course of the study.
- Patient has a known allergy to silicone (polymer and balloon material) or barium sulfate (polymer).
- Patient participated in another investigational drug or device study within the past 30 days.
- Patient belongs to a vulnerable population or has a condition such that his/her ability to provide informed consent, comply with follow-up requirements, or provide self assessments is compromised (e.g. developmentally disables, prisoner, chronic alcohol/ substance abuser)
- Patient has a disc herniation
- Patient has a Schmorl's node in the level to be treated
Intraoperative exclusion criteria:
- Protrusion of the 20A imaging balloon up to or beyond the outer margin of the vertebra during the imaging steps.
- Patient has a violated endplate.
- Patient has a disc space that is too narrow.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nucleus Replacement
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.
|
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of revision surgery at the treated level
Time Frame: 90 days
|
Number of patients requiring surgeries to revise the implanted level in the spine divided by the total number of implant surgeries.
Express in percentage (0-100)
|
90 days
|
Rate of expulsion
Time Frame: 90 Days
|
The rate of device expulsion.
The number of patients determined to have expulsed devices divided by the total number of patients receiving implants.Expressed in percentage (0-100)
|
90 Days
|
Rate of new herniation at the treated level as determined by MRI
Time Frame: 90 days
|
Herniation will be determine by MRI.
A herniation will be defined as violation of the intervertebral annulus, including expulsion of nucleus material.
The response will be yes/no as assessed by the radiologist.
Rate will be determined by total number of herniations divided by the total number of implanted devices.
Expressed in percentage (0-100)
|
90 days
|
Rate of new radiculopathy
Time Frame: 90 days
|
New complaint of leg pain will be recorded as a yes/no response.
Any complaint of new radiculopathy not seen preoperatively.
Expressed as total number of new radiculopathy complaints divided by total number of patients.
Expressed in percentage (0-100)
|
90 days
|
MRI assessment of the endplate Modic changes.
Time Frame: 90 days
|
Changes to vertebral endplates will be assigned based on Modic classification of I,II or III comparing preoperative grade to grade at 90 days.
Possible scores are I,II or III
|
90 days
|
Rate of surgical procedure technical success
Time Frame: 90 days
|
The number of devices successfully implanted divided by the number of successfully devices implanted + unsuccessful implants.
Output will be in percentage (0-100)
|
90 days
|
Improvement in degree of disability as measured by the Oswestry Disability Index (ODI)
Time Frame: 90 days
|
Change in absolute Oswestry Index score at 90 days compared to the preoperative score, range is 0-100
|
90 days
|
Improvement in back pain as measured by 10-centimeter Visual Analog Scale (VAS)
Time Frame: 90 days
|
Change in the Visual Analogue Scale (VAS) for back and leg pain on a scale of 0-10 cm comparing preoperative scores to 90 days post-operative.
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Anticipated)
January 31, 2022
Study Completion (Anticipated)
June 30, 2022
Study Registration Dates
First Submitted
June 26, 2019
First Submitted That Met QC Criteria
June 27, 2019
First Posted (Actual)
July 1, 2019
Study Record Updates
Last Update Posted (Actual)
July 19, 2021
Last Update Submitted That Met QC Criteria
July 13, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N181
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low-back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Federal University of ParaíbaCompletedChronic Low Back Pain | Nonspecific Chronic Low Back Pain
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Presidio Medical, IncRecruitingChronic Pain | Chronic Low-back PainAustralia
-
Spaulding Rehabilitation HospitalHighland Instruments, Inc.Active, not recruitingChronic Pain | Chronic Low Back PainUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Dan RhonNational Center for Complementary and Integrative Health (NCCIH); 59th Medical... and other collaboratorsRecruitingLow Back Pain | Chronic Pain | Surgery | Back Pain Lower Back Chronic | Back Pain, LowUnited States
Clinical Trials on PerQdisc® Nucleus Replacement Device.
-
Spinal Stabilization TechnologiesNot yet recruitingChronic Low-back Pain | Degenerative Disc DiseaseGermany
-
Spinal Stabilization TechnologiesRaylytic GmbHRecruitingBack Pain | Radiculopathy | Herniated Disc | Disk Herniated Lumbar | Back Pain With Radiation | Herniated Nucleus Pulposus | Disc Herniation | Disc InjuryParaguay
-
Spinal Stabilization TechnologiesRecruitingChronic Low-back Pain | Degenerative Disc DiseaseColombia, Paraguay
-
Spinal Stabilization TechnologiesActive, not recruitingChronic Low-back Pain | Degenerative Disc DiseaseParaguay
-
Vertebral Technologies, Inc.Unknown
-
Pioneer Surgical Technology, Inc.CompletedDegenerative Disc DiseaseUnited States
-
Becton, Dickinson and CompanyCompleted
-
Bruce J GantzCompletedHearing Loss, High-FrequencyUnited States
-
Kasey PhiferThe National Centre for ElectroMagnetic Therapies CICCompletedUnspecified Trauma- and Stressor-Related DisorderUnited Kingdom
-
MicroPort Orthopedics Inc.Terminated